ความสัมพันธ์ของความเครียดกับการเกิดโรคอัลไซเมอร์: ความเครียดกับการเกิดโรคอัลไซเมอร์

Ryden P

Authors

Ryden P Payap University, Chiang Mai Thailand

Keywords:

Alzheimer's diseases, stress, anxiety, PTST, glucocorticoids, cortisor

Abstract

The cause of Alzheimer’s disease still unclear; there is increasing evidence that chronic exposure to stress is a risk factor for Alzheimer’s and may also adversely affect the cause of the disease. Stress is becoming increasingly clear in neurodegenerative diseases, especially in the cognitive and memory areas of the brain where it can also disrupt neural circuits of stress responses. Disrupting these circuits produces abnormal emotional and aggressive behavior in patients. In addition, added stress drives the progression of the disease and can exacerbate symptoms. On the other hand, numerous prospective studies indicate that conditions associated with chronically elevated stress levels increase the risk of future dementia and Alzheimer’s disease. For instance, retrospective epidemiological studies provide robust evidence that a diagnosis of post-traumatic stress disorder is associated with an increased risk of dementia. This review, describes how neural and endocrine pathways activated by stress interact with ongoing Alzheimer’s disease and the relationship of stress and anxiety with Alzheimer’s. An increase in stress causes a more rapid development of pathology of the brain leads to Alzheimer’s disease.

References

Prince M, Comas-Herrera A, Knapp M, Guerchet M, Karagiannidou M. World Alzheimer report 2016: improving healthcare for people living with dementia: coverage, quality and costs now and in the future [Internet]. Alzheimer’s Disease International (ADI). 2016. [cited 2020 April 24]. Available from: http://www.alz.co.uk/

Thai Health Promotion Foundation. More than 6 hundred thousand Thai people have Alzheimer’s disease. Thaihealth.or.th [Internet]. Thaihealth.or.th. [cited 2020 Mar 30]. Available from: shorturl.at/kswAE

Selye H. Stress and the general adaptation syndrome. Br Med J. 1950;1:1383-92.

Dantzer R, O’Connor JC, Freund GG, Johnson RW, Kelley KW. From inflammation to sickness and depression: when the immune system subjugates the brain. Nat Rev Neurosci. 2008;9: 46-56.

El Husseini N, Laskowitz DT. The role of neuro-endocrine pathways in prognosis after stroke. Expert Rev Neurother. 2014;14:217-32.

Bortolato B, Hyphantis TN, Valpione S, Perini G, Maes M, Morris G, et al. Depression in cancer: The many biobehavioral pathways driving tumor progression. Cancer Treat Rev. 2017;52:58-70.

Crestani CC. Adolescent vulnerability to cardio-vascular consequences of chronic emotional stress: Review and perspectives for future research. Neurosci Biobehav Rev. 2017;74:466-75.

Canet G, Pineau F, Zussy C, Hernandez C, Hunt H, Chevallier N, et al. Glucocorticoid receptors signaling impairment potentiates amyloid-ß oligomers-induced pathology in an acute model of Alzheimer’s disease. FASEB J. 2020;34:1150-68.

Anacker C. Adult hippocampal neurogenesis in depression: Behavioral implications and regulation by the stress system. Curr Top Behav Neurosci 2014;18:25-43.

Chappel-Farley MG, Lui KK, Dave A, Chen IY, Mander BA. Candidate mechanisms linking insomnia disorder to Alzheimer’s disease risk. Curr Opin Behav Sci. 2020;33:92-8.

Hippius H, Neundörfer G. The discovery of Alzheimer’s disease. Dialogues Clin Neurosci. 2003;5:101-8.

Small GW, Rabins PV, Barry PP, Buckholtz NS, DeKosky ST, Ferris SH, et al. Diagnosis and treatment of Alzheimer disease and related disorders. Consensus statement of the American Association for Geriatric Psychiatry, the Alzheimer’s Association, and the American Geriatrics Society. JAMA. 1997;278:1363-71.

Castellani RJ, Rolston RK, Smith MA. Alzheimer disease. Dis Mon. 2010;56:484-546.

Braak H, Del Tredici K. The preclinical phase of the pathological process underlying sporadic Alzheimer’s disease. Brain. 2015;138:2814-33.

Barbier P, Zejneli O, Martinho M, Lasorsa A, Belle V, Smet-Nocca C, et al. Role of tau as a microtubule-associated protein: Structural and functional aspects. Front Aging Neurosci [Internet]. 2019. [cited 2020 April 17]. Available from: https://www.frontiersin.org/articles/10.3389/fnagi.2019.00204/full

Jack CR, Bennett DA, Blennow K, Carrillo MC, Dunn B, Haeberlein SB, et al. NIA-AA Research Framework: Toward a biological definition of Alzheimer’s disease. Alzheimers Dement. 2018; 14:535-62.

National Institute on Aging. Alzheimer’s Disease Fact Sheet [Internet]. National Institute on Aging. [cited 2020 April 15]. Available from: https://www.nia.nih.gov/health/alzheimers-disease-fact-sheet

Yang H, Hong W, Chen L, Tao Y, Peng Z, Zhou H. Analysis of risk factors for depression in Alzheimer’s disease patients. Int J Neurosci [Internet].2020 [cited 2020 April 26]. Available from: https://doi.org/10.1080/00207454.2020.1730369

Herman JP, McKlveen JM, Ghosal S, Kopp B, Wulsin A, Makinson R, et al. Regulation of the Hypothalamic-Pituitary-Adrenocortical Stress Response. Compr Physiol. 2016;6:603-21.

Escher CM, Sannemann L, Jessen F. Stress and Alzheimer’s disease. J Neural Transm. 2019; 126:1155-61.

Fiocco AJ, D’Amico D, de Beaumont L, Poirier J, Lupien S. Association between BDNF Polymorphism and Hypothalamic-Pituitary-Adrenal Activity in Later Adulthood. GER. 2020;66:131-7.

Shier D, Butler J, Lewis R. Hole’s Essentials of Human Anatomy & Physiology. 11st ed. New York: McGraw-Hill. 2012.

Bengtsson SKS, Bäckström T, Brinton R, Irwin RW, Johansson M, Sjöstedt J, et al. GABA-A receptor modulating steroids in acute and chronic stress;relevance for cognition and dementia? Neurobiology of Stress [Internet]. 2020 [cited 2020 April 26]. Available from: https://doi.org/10.1016/j.ynstr.2019.100206

Peterman JL, White JD, Calcagno A, Hagen C, Quiring M, Paulhus K, et al. Prolonged isolation stress accelerates the onset of Alzheimer’s disease-related pathology in 5xFAD mice despite running wheels and environmental enrichment. Behav Brain Res. 2020;379:112366.

Garcia-Banda G, Chellew K, Fornes J, Perez G, Servera M, Evans P. Neuroticism and cortisol: pinning down an expected effect. Int J Psychophysiol. 2014;91:132-8.

Green KN, Billings LM, Roozendaal B, McGaugh JL, LaFerla FM. Glucocorticoids increase amyloid-beta and tau pathology in a mouse model of Alzheimer’s disease. J Neurosci. 2006;26: 9047-56.

Sotiropoulos I, Catania C, Pinto LG, Silva R, Pollerberg GE, Takashima A, et al. Stress acts cumulatively to precipitate Alzheimer’s disease-like tau pathology and cognitive deficits. J Neurosci. 2011;31:7840-7.

Kamat PK, Kalani A, Rai S, Swarnkar S, Tota S, Nath C, et al. Mechanism of oxidative stress and synapse dysfunction in the pathogenesis of alzheimer’s disease: Understanding the therapeutics strategies. Mol Neurobiol. 2016; 53:648-61.

Ennis GE, An Y, Resnick SM, Ferrucci L, O’Brien RJ, Moffat SD. Long-term cortisol measures predict Alzheimer disease risk. Neurology. 2017;88: 371-8.

Ouanes S, Popp J. High Cortisol and the risk of dementia and alzheimer’s disease: A review of the literature. Front Aging Neurosci 2019;11:43.

Bisht K, Sharma K, Tremblay M-È. Chronic stress as a risk factor for Alzheimer’s disease: Roles of microglia-mediated synaptic remodeling, inflammation, and oxidative stress. Neurobiology of Stress. 2018;9:9-21.

Streit WJ, Khoshbouei H, Bechmann I. Dystrophic microglia in late-onset Alzheimer’s disease. Glia. 2020;68:845-54.

MedlinePlus. Post-traumatic stress disorder [Internet]. National Library of Medicine. [cited 2020 April 25]. Available from: https://medlineplus.gov/posttraumaticstressdisorder.html

Wang T-Y, Wei H-T, Liou Y-J, Su T-P, Bai Y-M, Tsai S-J, et al. Risk for developing dementia among patients with posttraumatic stress disorder: A nationwide longitudinal study. J Affect Disord. 2016;205:306-10.

Flatt JD, Gilsanz P, Quesenberry CP, Albers KB, Whitmer RA. Post-traumatic stress disorder and risk of dementia among members of a health care delivery system. Alzheimers Dement. 2018; 14:28-34.

Kim TD, Lee S, Yoon S. Inflammation in Post-Traumatic Stress Disorder (PTSD): A Review of Potential Correlates of PTSD with a Neurological Perspective. Antioxidants. 2020;9. pii: E107.

Yaffe K, Vittinghoff E, Lindquist K, Barnes D, Covinsky KE, Neylan T, et al. Posttraumatic stress disorder and risk of dementia among US veterans. Arch Gen Psychiatry. 2010;67:608-13.

Meziab O, Kirby KA, Williams B, Yaffe K, Byers AL, Barnes DE. Prisoner of war status, posttraumatic stress disorder, and dementia in older veterans. Alzheimers Dement. 2014;10:S236-41.

Kempuraj D, Ahmed ME, Selvakumar GP, Thangavel R, Raikwar SP, Zaheer SA, et al. Psychological stress–induced immune response and risk of alzheimer’s disease in veterans from operation enduring freedom and operation iraqi freedom. clinical therapeutics [Internet]. 2020 Mar 14. [cited 2020 Apr 20];pii: S0149-2918(20)30120-X. Available from: https://pubmed.ncbi.nlm.nih.gov/32184013/

Desmarais P, Weidman D, Wassef A, Bruneau M-A, Friedland J, Bajsarowicz P, et al. The interplay between post-traumatic stress disorder and dementia: A Systematic review. Am J Geriatr Psychiatry. 2020;28:48-60.

American Psychiatric Association. Diagnostic and statistical manual of mental disorders. 5th ed. Arlington, VA: APA Press; 2013.

How Is Generalized Anxiety Disorder Diagnosed Using the DSM-5? [Internet]. Verywell Mind. [cited 2020 August 6]. Available from: https://www.verywellmind.com/dsm-5-criteria-for-generalized-anxiety-disorder-1393147

Zhao Q-F, Tan L, Wang H-F, Jiang T, Tan M-S, Tan L, et al. The prevalence of neuropsychiatric symptoms in Alzheimer’s disease: systematic review and meta-analysis. J Affect Disord 2016:190:264–71.

Chanchaem R, Montientong D, Puanfai S. Prevalence of neuropsychiatric symptoms in patients with dementia; a study in Chiang Mai Neurological Hospital. J DMS. 2019;43:96-100.

Li X-X, Li Z. The impact of anxiety on the progression of mild cognitive impairment to dementia in Chinese and English data bases: a systematic review and meta-analysis. Int J Geriatr Psychiatry. 2018;33:131-40.

Donovan NJ, Locascio JJ, Marshall GA, Gatchel J, Hanseeuw BJ, Rentz DM, et al. Longitudinal association of amyloid beta and anxious-depressive symptoms in cognitively normal older adults. Am J Psychiatry. 2018;175:530-7.

Hanseeuw BJ, Jonas V, Jackson J, Betensky RA, Rentz DM, Johnson KA, et al. Association of anxiety with subcortical amyloidosis in cognitively normal older adults. Mol Psychiatry [Internet]. 2018 Aug 16 [cited 2020 Aug 28]; Available from: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6377864/

Perin S, Harrington KD, Lim YY, Ellis K, Ames D, Pietrzak RH, et al. Amyloid burden and incident depressive symptoms in preclinical Alzheimer’s disease. J Affect Disord. 2018;229:269-74.

Pietrzak RH, Lim YY, Neumeister A, Ames D, Ellis KA, Harrington K, et al. Amyloid-beta, anxiety, and cognitive decline in preclinical Alzheimer disease: a multicenter, prospective cohort study. JAMA Psychiatry. 2015; 72:284–91.

Petkus AJ, Reynolds CA, Wetherell JL, Kremen WS, Pedersen NL, Gatz M. Anxiety is associated with increased risk of dementia in older SwedishTwins. Alzheimers Dement. 2016;12:399–406.